Your browser doesn't support javascript.
loading
Small airway dysfunction in chronic hypersensitivity pneumonitis.
Guerrero Zúñiga, Selene; Sánchez Hernández, Julia; Mateos Toledo, Heidegger; Mejía Ávila, Mayra; Gochicoa-Rangel, Laura; Miguel Reyes, José Luis; Selman, Moisés; Torre-Bouscoulet, Luis.
Afiliación
  • Guerrero Zúñiga S; Department of Respiratory Physiology, National Institute of Respiratory Diseases, Mexico City, Mexico.
  • Sánchez Hernández J; Department of Respiratory Physiology, National Institute of Respiratory Diseases, Mexico City, Mexico.
  • Mateos Toledo H; Interstitial Lung Diseases Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico.
  • Mejía Ávila M; Interstitial Lung Diseases Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico.
  • Gochicoa-Rangel L; Department of Respiratory Physiology, National Institute of Respiratory Diseases, Mexico City, Mexico.
  • Miguel Reyes JL; Asthma Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico.
  • Selman M; Research Unit, National Institute of Respiratory Diseases, Mexico City, Mexico.
  • Torre-Bouscoulet L; Department of Respiratory Physiology, National Institute of Respiratory Diseases, Mexico City, Mexico.
Respirology ; 22(8): 1637-1642, 2017 11.
Article en En | MEDLINE | ID: mdl-28748646
BACKGROUND AND OBJECTIVE: Lung biopsies from patients with hypersensitivity pneumonitis (HP) have demonstrated small airway (SA) involvement, but there is no information concerning SA function in HP, and it is unknown whether pharmacological treatment could modify its function. SA function in patients with chronic HP using ultrasonic pneumography (UPG) and impulse oscillometry (IOS) was explored. We also compared initial results with those obtained after 4 weeks of standardized treatment with azathioprine and prednisone. METHODS: The study group consisted of adults with recent diagnoses of HP. All patients completed UPG, IOS, spirometry, body plethysmography, single-breath carbon monoxide diffusing capacity (DLCO ) and the 6-min walk test (6MWT). The fraction of exhaled nitric oxide (FENO ) was obtained to assess eosinophilic airway inflammation. Measurements were taken at diagnosis and after 4 weeks of treatment. RESULTS: A total of 20 consecutive patients (16 women) with chronic HP participated in the study. Median age was 50 years (interquartile range (IQR): 42-54). At diagnosis, the UPG phase 3 slope was abnormally high, consistent with maldistribution of ventilation. For IOS, all patients had low reactance at 5 Hz (X5) and elevated reactance area (AX) reflecting low compliance, and only eight (40%) patients had elevated R5 (resistance at 5 Hz (total)) and R5-20 (resistance at 5 Hz-resistance at 20 Hz (peripheral)) attributed to SA resistance. In contrast, FENO parameters were within normal limits. After treatment, forced vital capacity (FVC), the 6-min walk distance and the distribution of ventilation showed significant improvement, although DLCO did not. CONCLUSION: Patients with chronic HP have SA abnormalities that are partially revealed by the UPG and IOS tests. Lung volumes, but not gas exchange, improved after treatment with azathioprine and prednisone.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azatioprina / Prednisolona / Alveolitis Alérgica Extrínseca / Pulmón Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Respirology Año: 2017 Tipo del documento: Article País de afiliación: México Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azatioprina / Prednisolona / Alveolitis Alérgica Extrínseca / Pulmón Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Respirology Año: 2017 Tipo del documento: Article País de afiliación: México Pais de publicación: Australia